Hanscom, Thomas, M.D.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving Bevacizumab (NCT01471691) | Hanscom, Thomas, M.D. | 2011-11-01 |
Track Hanscom, Thomas, M.D. automatically
Every clearance here is in the API, with alerts when new ones post.